Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides

By sjmartinez • July 1, 2025

Murugesan P, Zhang Y, Zhang Y, Youn JY, Cai H. Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides. Redox Biol. 2025 Jun 13;85:103710. doi: 10.1016/j.redox.2025.103710. Epub ahead of print. PMID: 40580754.

Tags: Cardiology/Epi, Endothelial nitric oxide synthase uncoupling, eNOS, hypoxia, Mitochondrial superoxide production, Netrin-1, Netrin-1 derived small peptides, NO bioavailability, Publications, pulmonary hypertension, Pulmonary vascular remodeling, reactive oxygen species, Right ventricular hypertrophy, ROS, Translational

Related Posts

Brief Report: Association of HIV and HCV With Adverse Coronary Artery Phenotypes in Women: Findings From a Cross-Sectional Study

Shitole SG, Chen E, Naveed M, Xue X, Sharma A, Hanna DB, Anastos K, Kaplan RC, Levsky JM, Tien PC, Radparvar AA, Bortnick AE, Budoff[...]

A microbiome quantitative trait locus in SLC39A8 modulates disease severity in synucleinopathy-induced models of Parkinson’s disease

Yang JC, Situ J, Troutman R, Zhu R, Black M, Buri H, Gutta A, Tian F, Kang A, Aja E, Zeng A, Lai RW, Tan[...]

Latency of Hypertensive Disorders of Pregnancy and Cardiovascular Risk 2-7 Years After Delivery

Shree S, Pike M, Yee LM, Levine L, Simhan H, Silver RM, Greenland P, Saade G, Bairey Merz CN, Chung J, Cleary EM, Grobman W,[...]